Nuveen’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Nuveen’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-97,546	Closed	-$3.51M	–	3185
2022 Q4	$3.51M	Sell	97,546 -5,521	-5%	-$138K	﹤0.01%	2116
2022 Q3	$1.55M	Sell	103,067 -2,298	-2%	-$37.3K	﹤0.01%	2531
2022 Q2	$1.41M	Buy	105,365 +52,312	+99%	+$830K	﹤0.01%	2620
2022 Q1	$954K	Buy	53,053 +39,318	+286%	+$816K	﹤0.01%	2832
2021 Q4	$242K	Hold	13,735	–	–	﹤0.01%	3212
2021 Q3	$275K	Buy	+13,735	New	+$295K	﹤0.01%	3262

Nuveen's IMGO Position: Q1 2023 in Review

Nuveen sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 97,546 shares — an estimated $3.51M sold.

Nuveen first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $3.51M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Nuveen reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Nuveen sold 97,546 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $3.51M.
Nuveen first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
Nuveen's Imago BioSciences, Inc. Common stock position peaked at $3.51M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Nuveen's 13F filing for Q1 2023, filed 15 May 2023.